Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Filip Gerard Verberckmoes has worked on the following 20 EPO patent applications which have been published in the last five years:

EP12766452

IMPROVED PROCESS FOR PREPARING 2-[(2E)-2-FLUORO-2-(3-PIPERIDINYLIDENE)ETHYL]-1H-ISOINDOLE-1,3(2H)-DIONE

IPC classification:
C07D 211/70, C07D 401/04, C07F 9/24
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13702653

METHOD TO PREVENT DEACTIVATION OF METAL CATALYSTS IN CATALYTIC POLYMERISATION PROCESSES

IPC classification:
A01N 43/40, C08F 2/44, C08F 4/42, C09D 5/16
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13707638

USE OF TRALOPYRIL AGAINST MARINE WOODBORERS

IPC classification:
A01N 25/02, A01N 43/36, A01P 9/00, B27K 3/34
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP11796711

IMIDAZOPYRIDINES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04, C07D 487/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11799682

AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13728403

4 - SUBSTITUTED 1, 3 - DIHYDRO - 2H - BENZIMIDAZOL - 2 - ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 11/00, C07D 235/20, C07D 235/26, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13730845

1,3 -DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 31/12, C07D 403/06, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728749

1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61K 31/4709, A61P 11/00, A61P 31/12, C07D 413/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728404

1,3 -DIHYDRO- 2H-BENZIMIDAZOL- 2 -ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4184, A61K 31/437, A61P 31/12, C07D 403/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP14701389

QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
C07D 403/06, C07D 403/14, C07D 471/04
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11794793

INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 403/06, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14744362

SUBSTITUTED PYRIDINE-PIPERAZINYL ANALOGUES AS RSV ANTIVIRAL COMPOUNDS

IPC classification:
C07D 403/04, C07D 403/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION IN PROGRESS
EP15193770

SYNERGISTIC IMAZALIL COMBINATIONS

IPC classification:
A01N 43/50, A01N 57/12, A01P 3/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP16155033

BIOCIDAL COMPOSITION COMPRISING A THIOL GROUP MODULATING ENZYME INHIBITOR AND PYRION COMPOUND

IPC classification:
A01N 43/40, A01N 47/14, A01N 59/16, A01P 1/00, A01P 3/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Johnson & Johnson
Status:
EXAMINATION REQUESTED
EP11728629

ANTIMICROBIAL COMBINATIONS OF PYRION COMPOUNDS WITH POLYETHYLENEIMINES

IPC classification:
A01N 43/40, A01P 1/00, A61K 31/44, A61K 31/785, A61L 2/18, B27K 3/50, C02F 1/50, C10M 161/00
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11794794

AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

IPC classification:
A61K 31/437, A61P 31/12, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11802054

BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS INHIBITORS

IPC classification:
A61K 31/4188, A61P 11/00, C07D 235/26, C07D 471/04
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15714532

SPIRO UREA COMPOUNDS AS RSV ANTIVIRAL COMPOUNDS

IPC classification:
A61K 31/407, A61K 31/4184, A61K 31/437, A61P 31/14, C07D 487/10
Applicant:
Janssen Sciences Ireland UC
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
EXAMINATION REQUESTED
EP15771593

MONO- OR DI-SUBSTITUTED INDOLES AS DENGUE VIRAL REPLICATION INHIBITORS

IPC classification:
A61K 31/404, A61P 31/12, C07D 209/42
Applicant:
Katholieke Universiteit Leuven
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made
EP15771136

MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS

IPC classification:
A61K 31/404, A61P 31/12, C07D 209/42
Applicant:
Katholieke Universiteit Leuven
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Filip Gerard Verberckmoes, Janssen Pharmaceutica N.V.
Status:
Request for examination was made

Please Sign in to use this feature